EXHIBIT
31.2

CERTIFICATION
OF PRINCIPAL FINANCIAL OFFICER

PURSUANT
TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I,
Michael Kramarz, certify that:

|(1) |  | I have reviewed this Annual
Report on Form 10-K of Oncologix Tech, Inc.;
|--- |  | ------------------------------------------------------------------------

|(2) |  | Based on my knowledge, the
Report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by the Report;
|--- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(3) |  | Based
                                         on my knowledge, the financial statements, and other financial information included in
                                         the Report, fairly present in all material respects the financial condition, results
                                         of operations and cash flows of the registrant as of, and for, the periods represented
                                         in this report;
|--- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(4) |  | The
                                         registrant’s other certifying officer and I are responsible for establishing and
                                         maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
                                         and 15d-15(e) and internal control over financial reporting (as defined in Exchange Act
                                         Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|--- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| |  | 
| |  | 

|(a) |  | Designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others with these entities, particularly during the period in which this
Report is being prepared;
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------





|(b) |  | Designed
                                         such internal control over financial reporting, or caused such internal control over
                                         financial reporting to be designed under our supervision, to provide reasonable assurance
                                         regarding the reliability of financial reporting and the preparation of financial statements
                                         for external purposes in accordance with generally accepted accounting principles;
|--- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(c) |  | Evaluated
                                         the effectiveness of the registrant’s disclosure controls and procedures and presented
                                         in Report our conclusions about the effectiveness of the disclosure controls and procedures,
                                         as of the end of the period covered by this Report based on such evaluation; and
|--- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(d) |  | Disclosed
                                         in this Report any change in the registrant’s internal control over financial reporting
                                         that occurred during the registrant’s most recent fiscal quarter (the registrant’s
                                         fourth fiscal quarter in case of an annual report) that has materially affected, or is
                                         reasonably likely to materially affect, the registrant’s internal control over
                                         financial reporting.
|--- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(6) |  | The
                                         registrant’s other certifying officer and I have disclosed, based on our most recent
                                         evaluation of internal control over financial reporting, to the registrant’s auditors
                                         and the audit committee of the Registrant’s board of directors (or persons performing
                                         the equivalent functions):
|--- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(a) |  | All
                                         significant deficiencies and material weaknesses in the design or operation of internal
                                         control over financial reporting which are reasonably likely toadversely affect
                                         the registrant’s ability to record, process, summarize and report financialinformation;and
|--- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(b) |  | Any
                                         fraud, whether or not material, that involves management or other employees who have
                                         a significant role in the registrant’s internal control over financial reporting.
|--- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|Date: December
    16, 2013 | Oncologix Tech, Inc.
|--------------------------- | --------------------
|                            | By                  
|                            |